Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$432M |
| 3 |
Abbott
ABT
|
+$420M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$277M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
+$472M |
| 2 |
Bank of America
BAC
|
+$426M |
| 3 |
TE Connectivity
TEL
|
+$399M |
| 4 |
Atlassian
TEAM
|
+$364M |
| 5 |
Goldman Sachs
GS
|
+$348M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.8% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Scansource
SCSC
$973M
| $437K | ﹤0.01% |
11,052
-20
| -0.2% | -$792 |
|
2052
RxSight
RXST
$366M
| $437K | ﹤0.01% |
10,844
-10
| -0.1% | -$403 |
|
2053
Lemonade
LMND
$3.91B
| $437K | ﹤0.01% |
27,106
-36
| -0.1% | -$580 |
|
2054
1st Source
SRCE
$1.58B
| $436K | ﹤0.01% |
7,935
-7
| -0.1% | -$385 |
|
2055
Nu Skin
NUS
$570M
| $434K | ﹤0.01% |
22,326
-42
| -0.2% | -$816 |
|
2056
CVR Energy
CVI
$3.16B
| $433K | ﹤0.01% |
14,285
-24
| -0.2% | -$727 |
|
|
INBX
2057
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $432K | ﹤0.01% |
11,358
-17
| -0.1% | -$646 |
|
2058
Monro
MNRO
$527M
| $429K | ﹤0.01% |
14,601
-25
| -0.2% | -$734 |
|
2059
Fresh Del Monte Produce
FDP
$1.72B
| $429K | ﹤0.01% |
16,327
-30
| -0.2% | -$787 |
|
2060
Southside Bancshares
SBSI
$926M
| $428K | ﹤0.01% |
13,678
-26
| -0.2% | -$814 |
|
|
DCPH
2061
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $428K | ﹤0.01% |
26,537
-90
| -0.3% | -$1.45K |
|
2062
Perella Weinberg Partners
PWP
$1.39B
| $426K | ﹤0.01% |
34,853
+12,032
| +53% | +$147K |
|
2063
Eagle Bancorp
EGBN
$602M
| $425K | ﹤0.01% |
14,136
-23
| -0.2% | -$692 |
|
2064
Ichor Holdings
ICHR
$575M
| $425K | ﹤0.01% |
12,632
-21
| -0.2% | -$707 |
|
2065
Hovnanian Enterprises
HOV
$906M
| $425K | ﹤0.01% |
+2,724
| New | +$425K |
|
2066
Symbotic
SYM
$5.3B
| $423K | ﹤0.01% |
8,231
+23
| +0.3% | +$1.18K |
|
2067
Graco
GGG
$14.2B
| $422K | ﹤0.01% |
4,864
-133
| -3% | -$11.5K |
|
2068
ADMA Biologics
ADMA
$3.92B
| $422K | ﹤0.01% |
93,272
-147
| -0.2% | -$665 |
|
2069
Hain Celestial
HAIN
$168M
| $422K | ﹤0.01% |
38,532
-69
| -0.2% | -$755 |
|
2070
Compass
COMP
$5.02B
| $421K | ﹤0.01% |
111,834
-134
| -0.1% | -$504 |
|
2071
Leonardo DRS
DRS
$10.9B
| $419K | ﹤0.01% |
20,894
+5
| +0% | +$100 |
|
2072
AMC Entertainment Holdings
AMC
$1.45B
| $419K | ﹤0.01% |
68,453
+509
| +0.7% | +$3.11K |
|
2073
Warby Parker
WRBY
$3.26B
| $418K | ﹤0.01% |
29,623
-59
| -0.2% | -$832 |
|
2074
Vaalco Energy
EGY
$396M
| $418K | ﹤0.01% |
93,050
+4,280
| +5% | +$19.2K |
|
2075
Southern Copper
SCCO
$84B
| $417K | ﹤0.01% |
5,083
-71
| -1% | -$5.82K |
|